Order Article Reprints

Hamadi A, Mir R, Mahzari A, Hakami A, Almotairi R, Dobie G, Hamdi F, Nahari MH, Alhefzi R, Alasseiri M, et al. Molecular Determination of Vascular Endothelial Growth Factor, miRNA-423 Gene Abnormalities by Utilizing ARMS-PCR and Their Association with Fetal Hemoglobin Expression in the Patients with Sickle Cell Disease. Current Issues in Molecular Biology. 2022; 44(6):2569-2582. https://doi.org/10.3390/cimb44060175

Hamadi, Abdullah, Rashid Mir, Ali Mahzari, Abdulrahim Hakami, Reema Almotairi, Gasim Dobie, Fawaz Hamdi, Mohammed Hassan Nahari, Razan Alhefzi, Mohammed Alasseiri, and et al. 2022. "Molecular Determination of Vascular Endothelial Growth Factor, miRNA-423 Gene Abnormalities by Utilizing ARMS-PCR and Their Association with Fetal Hemoglobin Expression in the Patients with Sickle Cell Disease" Current Issues in Molecular Biology 44, no. 6: 2569-2582. https://doi.org/10.3390/cimb44060175

Hamadi, A., Mir, R., Mahzari, A., Hakami, A., Almotairi, R., Dobie, G., Hamdi, F., Nahari, M. H., Alhefzi, R., Alasseiri, M., Hakami, N. Y., Al Sadoun, H., Al-Amer, O. M., Barnawi, J., & Madkhali, H. A. (2022). Molecular Determination of Vascular Endothelial Growth Factor, miRNA-423 Gene Abnormalities by Utilizing ARMS-PCR and Their Association with Fetal Hemoglobin Expression in the Patients with Sickle Cell Disease. Current Issues in Molecular Biology, 44(6), 2569-2582. https://doi.org/10.3390/cimb44060175